In summary, our findings suggest that inhibiting METTL1 alone or in combination with chemotherapeutic agents could enhance the elimination of cancer cells within a tumour by rendering them more susceptible to genotoxic stress and increasing their responsiveness to chemotherapy. This evidence concerns the gene METTL1 and neoplasm.